keyword
https://read.qxmd.com/read/38641413/inhibition-of-neuron-restrictive-silencing-factor-rest-nrsf-chromatin-binding-attenuates-epileptogenesis
#1
JOURNAL ARTICLE
Alicia M Hall, Noriko Kamei, Manlin Shao, Hyun-Seung Mun, Kevin Chen, Yuncai Chen, Tallie Z Baram
The mechanisms by which brain insults lead to subsequent epilepsy remain unclear. Insults including trauma, stroke, infections and long seizures (status epilepticus; SE) increase the nuclear expression and chromatin binding of the neuronal restrictive silencing factor / RE-1 silencing transcription factor (NRSF/REST). REST/NRSF orchestrates major disruption of the expression of key neuronal genes, including ion channels and neurotransmitter receptors, potentially contributing to epileptogenesis. Accordingly, transient interference with REST/NRSF chromatin binding after an epilepsy-provoking SE suppressed spontaneous seizures for the 12- day duration of a prior study...
April 19, 2024: ENeuro
https://read.qxmd.com/read/38636579/neuroprotective-potential-of-traditionally-used-medicinal-plants-of-manipur-against-rotenone-induced-neurotoxicity-in-sh-sy5y-neuroblastoma-cells
#2
JOURNAL ARTICLE
Aruna Chanu Hijam, Yaiphabi Chanu Tongbram, Pooja Devi Nongthombam, Heikrujam Nilkanta Meitei, Arunkumar Singh Koijam, Yallapa Rajashekar, Reena Haobam
ETHNOPHARMACOLOGICAL RELEVANCE: Alternanthera sessilis (L.) R. Br. ex DC., Eryngium foetidum L., and Stephania japonica (Thunb.) Miers plants are traditionally used to treat various central nervous system disorders like paralysis, epilepsy, seizure, convulsion, chronic pain, headache, sleep disturbances, sprain, and mental disorders. However, their possible neuroprotective effects have not been evaluated experimentally so far. AIM OF THE STUDY: The study aims to examine the neuroprotective potential of the three plants against cytotoxicity induced by rotenone in SH-SY5Y neuroblastoma cells and assess its plausible mechanisms of neuroprotection...
April 16, 2024: Journal of Ethnopharmacology
https://read.qxmd.com/read/38633326/case-report-a-developmental-and-epileptic-encephalopathy-45-due-to-de-novo-variant-of-gabrb1
#3
Lu Wang, Haiquan Xu, Jianbo Shu, Dandan Yan, Dong Li, Chunquan Cai
BACKGROUND: The gamma-aminobutyric acid (GABA) variant causes developmental and epileptic encephalopathy 45 (DEE45), an autosomal dominant disorder that results in oculocortical visual impairment, reduced muscle tone, psychomotor retardation, and epilepsy. Analysis of the clinical features and genetics of DEE45 may be helpful in complementing genotype-phenotype studies. CASE PRESENTATION: We collected peripheral blood samples from the affected children and parents and extracted genomic DNA...
2024: Frontiers in Pediatrics
https://read.qxmd.com/read/38587324/effect-of-levetiracetam-on-dna-oxidation-and-glutathione-content-in-a-temporal-lobe-epilepsy-model
#4
JOURNAL ARTICLE
Itzel Jatziri Contreras-García, Cindy Bandala, Iván Ignacio-Mejía, Luz Adriana Pichardo-Macías, Julieta Griselda Mendoza-Torreblanca, Mercedes Edna García-Cruz, Saúl Gómez-Manzo, Noemí Cárdenas-Rodríguez
Levetiracetam (LEV) is a drug commonly used as an anticonvulsant. However, recent evidence points to a possible role as an antioxidant. We previously demonstrated the antioxidant properties of LEV by significantly increasing catalase and superoxide dismutase activities and decreasing the hydrogen peroxide (H2O2) levels in the hippocampus of rats with temporal lobe epilepsy (TLE) showing scavenging properties against the hydroxyl radical. The aim of the present work was to evaluate, the effect of LEV on DNA oxidation, by determining 8‑hydroxy‑2‑deoxyguanosine (8‑OHdG) levels, and glutathione content, through reduced (GSH) and oxidized (GSSG) glutathione levels, in the hippocampus of rats with TLE...
March 28, 2024: Acta Neurobiologiae Experimentalis
https://read.qxmd.com/read/38587282/identification-of-a-mosaic-mtor-variant-in-purified-neuronal-dna-in-a-patient-with-focal-cortical-dysplasia-using-a-novel-depth-electrode-harvesting-technique
#5
JOURNAL ARTICLE
Karl Martin Klein, Rumika Mascarenhas, Daria Merrikh, Maryam Khanbabaei, Tatiana Maroilley, Navprabhjot Kaur, Yiping Liu, Tyler Soule, Minette Manalo, Goichiro Tamura, Julia Jacobs, Walter Hader, Gerald Pfeffer, Maja Tarailo-Graovac
OBJECTIVE: Recent studies have identified brain somatic variants as a cause of focal epilepsy. These studies relied on resected tissue from epilepsy surgery, which is not available in most patients. The use of trace tissue adherent to depth electrodes used for stereo electroencephalography (EEG) has been proposed as an alternative but is hampered by the low cell quality and contamination by nonbrain cells. Here, we use our improved depth electrode harvesting technique that purifies neuronal nuclei to achieve molecular diagnosis in a patient with focal cortical dysplasia (FCD)...
April 8, 2024: Epilepsia
https://read.qxmd.com/read/38570685/ancestral-allele-of-dna-polymerase-gamma-modifies-antiviral-tolerance
#6
JOURNAL ARTICLE
Yilin Kang, Jussi Hepojoki, Rocio Sartori Maldonado, Takayuki Mito, Mügen Terzioglu, Tuula Manninen, Ravi Kant, Sachin Singh, Alaa Othman, Rohit Verma, Johanna Uusimaa, Kirmo Wartiovaara, Lauri Kareinen, Nicola Zamboni, Tuula Anneli Nyman, Anders Paetau, Anja Kipar, Olli Vapalahti, Anu Suomalainen
Mitochondria are critical modulators of antiviral tolerance through the release of mitochondrial RNA and DNA (mtDNA and mtRNA) fragments into the cytoplasm after infection, activating virus sensors and type-I interferon (IFN-I) response1-4 . The relevance of these mechanisms for mitochondrial diseases remains understudied. Here we investigated mitochondrial recessive ataxia syndrome (MIRAS), which is caused by a common European founder mutation in DNA polymerase gamma (POLG1)5 . Patients homozygous for the MIRAS variant p...
April 3, 2024: Nature
https://read.qxmd.com/read/38549412/-supratentorial-neuroepithelial-tumor-with-plagl1-gene-fusion-a-new-type-of-morphologically-variable-pediatric-brain-neoplasm-defined-by-a-distinct-dna-methylation-class-a-case-report-and-literature-review
#7
JOURNAL ARTICLE
D N Kopachev, M V Ryzhova, A N Kislyakov, E G Shaikhaev, O G Zheludkova, E V Kumirova, S V Meshcheryakov, P A Vlasov, A M Shkatova, Zh B Semenova, A O Gushcha
BACKGROUND: Methylation analysis has become a powerful diagnostic tool in modern neurooncology. This technique is valuable to diagnose new brain tumor types. OBJECTIVE: To describe the MRI and histological pattern of neuroepithelial tumor with PLAGL1 gene fusion. MATERIAL AND METHODS: We present a 6-year-old patient with small right frontal intraaxial tumor causing drug resistant epilepsy. Despite indolent preoperative clinical course and MRI features suggesting glioneuronal tumor, histological evaluation revealed characteristics of high-grade glioma, ependymoma and neuroblastoma...
2024: Zhurnal Voprosy Neĭrokhirurgii Imeni N. N. Burdenko
https://read.qxmd.com/read/38540409/leukodystrophy-with-macrocephaly-refractory-epilepsy-and-severe-hyponatremia-the-neonatal-type-of-alexander-disease
#8
Justyna Paprocka, Magdalena Nowak, Magdalena Machnikowska-Sokołowska, Karolina Rutkowska, Rafał Płoski
INTRODUCTION: Alexander disease (AxD) is a rare neurodegenerative condition that represents the group of leukodystrophies. The disease is caused by GFAP mutation. Symptoms usually occur in the infantile age with macrocephaly, developmental deterioration, progressive quadriparesis, and seizures as the most characteristic features. In this case report, we provide a detailed clinical description of the neonatal type of AxD. METHOD: Next-Generation Sequencing (NGS), including a panel of 49 genes related to Early Infantile Epileptic Encephalopathy (EIEE), was carried out, and then Whole Exome Sequencing (WES) was performed on the proband's DNA extracted from blood...
March 11, 2024: Genes
https://read.qxmd.com/read/38516039/correlation-of-telomere-length-in-brain-tissue-with-peripheral-tissues-in-living-human-subjects
#9
JOURNAL ARTICLE
Annemarie J Carver, Benjamin Hing, Benjamin A Elser, Stephanie J Lussier, Takehiko Yamanashi, Matthew A Howard, Hiroto Kawasaki, Gen Shinozaki, Hanna E Stevens
Telomeres are important to chromosomal stability, and changes in their length correlate with disease, potentially relevant to brain disorders. Assessing telomere length in human brain is invasive, but whether peripheral tissue telomere length correlates with that in brain is not known. Saliva, buccal, blood, and brain samples were collected at time points before, during, and after subjects undergoing neurosurgery ( n = 35) for intractable epilepsy. DNA was isolated from samples and average telomere length assessed by qPCR...
2024: Frontiers in Molecular Neuroscience
https://read.qxmd.com/read/38511224/epigenetics-and-the-neurodegenerative-process
#10
REVIEW
Bartosz Słowikowski, Wojciech Owecki, Jan Jeske, Michał Jezierski, Michał Draguła, Ulyana Goutor, Paweł P Jagodziński, Wojciech Kozubski, Jolanta Dorszewska
Neurological diseases are multifactorial, genetic and environmental. Environmental factors such as diet, physical activity and emotional state are epigenetic factors. Environmental markers are responsible for epigenetic modifications. The effect of epigenetic changes is increased inflammation of the nervous system and neuronal damage. In recent years, it has been shown that epigenetic changes may cause an increased risk of neurological disorders but, currently, the relationship between epigenetic modifications and neurodegeneration remains unclear...
March 21, 2024: Epigenomics
https://read.qxmd.com/read/38507296/impact-of-abcb1-genetic-polymorphism-on-carbamazepine-dose-requirement-among-southern-indian-persons-with-epilepsy
#11
JOURNAL ARTICLE
Elango Dhivya, Ramasamy Kesavan, Nair P Pradeep
OBJECTIVES: Carbamazepine (CBZ) is one of the oldest, yet first line drugs for treating epilepsy. However, there is a large inter-individual difference in requirement of maintenance dose and one third of persons treated with antiepileptic drugs (AEDs) exhibit drug resistance to therapy. One of the proposed mechanisms for the drug resistance was increased expression of efflux transporter P-glycoprotein. The pharmacogenetic studies of drug transporters ( ABCB1 ) done in combination therapies of AEDs were inconclusive...
March 20, 2024: Drug Metabolism and Personalized Therapy
https://read.qxmd.com/read/38495109/aav8-vector-induced-gliosis-following-neuronal-transgene-expression
#12
JOURNAL ARTICLE
Faye McLeod, Elaine McDermott, Shermin Mak, Darren Walsh, Mark Turnbull, Fiona E N LeBeau, Andrew Jackson, Andrew J Trevelyan, Gavin J Clowry
INTRODUCTION: Expression of light sensitive ion channels by selected neurons has been achieved by viral mediated transduction with gene constructs, but for this to have therapeutic uses, for instance in treating epilepsy, any adverse effects of viral infection on the cerebral cortex needs to be evaluated. Here, we assessed the impact of adeno-associated virus 8 (AAV8) carrying DNA code for a soma targeting light activated chloride channel/FusionRed (FR) construct under the CKIIa promoter...
2024: Frontiers in Neuroscience
https://read.qxmd.com/read/38491957/somatic-variants-as-a-cause-of-drug-resistant-epilepsy-including-mesial-temporal-lobe-epilepsy-with-hippocampal-sclerosis
#13
JOURNAL ARTICLE
Robert J Carton, Michael G Doyle, Hugh Kearney, Charles A Steward, Nicholas J Lench, Anthony Rogers, Erin L Heinzen, Seamus McDonald, Joanna Fay, Austin Lacey, Alan Beausang, Jane Cryan, Francesca Brett, Hany El-Naggar, Peter Widdess-Walsh, Daniel Costello, Ronan Kilbride, Colin P Doherty, Kieron J Sweeney, Donncha F O'Brien, David C Henshall, Norman Delanty, Gianpiero L Cavalleri, Katherine A Benson
OBJECTIVE: The contribution of somatic variants to epilepsy has recently been demonstrated, particularly in the etiology of malformations of cortical development. The aim of this study was to determine the diagnostic yield of somatic variants in genes that have been previously associated with a somatic or germline epilepsy model, ascertained from resected brain tissue from patients with multidrug-resistant focal epilepsy. METHODS: Forty-two patients were recruited across three categories: (1) malformations of cortical development, (2) mesial temporal lobe epilepsy with hippocampal sclerosis, and (3) nonlesional focal epilepsy...
March 16, 2024: Epilepsia
https://read.qxmd.com/read/38438430/assessment-of-parental-mosaicism-rates-in-neurodevelopmental-disorders-caused-by-apparent-de-novo-pathogenic-variants-using-deep-sequencing
#14
JOURNAL ARTICLE
François Lecoquierre, Kévin Cassinari, Nathalie Drouot, Angèle May, Steeve Fourneaux, Francoise Charbonnier, Celine Derambure, Sophie Coutant, Pascale Saugier-Veber, Alexander Hoischen, Camille Charbonnier, Gaël Nicolas
While de novo variants (DNV) are overall at low risk of recurrence in subsequent pregnancies, a subset is at high risk due to parental mosaicism. Accurately identifying cases of parental mosaicism is therefore important for genetic counseling in clinical care. Some studies have investigated the rate of parental mosaics, but most were either limited by the sensitivity of the techniques (i.e. exome or genome sequencing), or focused on specific types of disease such as epileptic syndromes. This study aimed to determine the proportion of parental mosaicism among the DNV causing neurodevelopmental disorders (NDDs) in a series not enriched in epilepsy syndromes...
March 4, 2024: Scientific Reports
https://read.qxmd.com/read/38433132/a-novel-pathogenic-variant-in-tdp2-causes-spinocerebellar-ataxia-autosomal-recessive-23-accompanied-by-pituitary-tumor-and-hyperhidrosis-a-case-report
#15
JOURNAL ARTICLE
Yuqiu Zheng, Yingfang She, Zhengwei Su, Kanghui Huang, Shuda Chen, Liemin Zhou
TDP2 gene encodes tyrosyl DNA phosphodiesterase 2, an enzyme required for effective repair of the DNA double-strand breaks (DSBs). Spinocerebellar ataxia autosomal recessive 23 (SCAR23) is a rare disease caused by the pathogenic mutation of TDP2 gene and characterized by intellectual disability, progressive ataxia and refractory epilepsy. Thus far, merely nine patients harboring five different variants (c.425 + 1G > A; c.413_414delinsAA, p. Ser138*; c.400C > T, p...
March 4, 2024: Neurological Sciences
https://read.qxmd.com/read/38419903/sleep-mood-disorders-and-the-ketogenic-diet-potential-therapeutic-targets-for-bipolar-disorder-and-schizophrenia
#16
REVIEW
Jinyoung Choi, Jiseung Kang, Tae Kim, Christa J Nehs
Bipolar disorder and schizophrenia are serious psychiatric conditions that cause a significant reduction in quality of life and shortened life expectancy. Treatments including medications and psychosocial support exist, but many people with these disorders still struggle to participate in society and some are resistant to current therapies. Although the exact pathophysiology of bipolar disorder and schizophrenia remains unclear, increasing evidence supports the role of oxidative stress and redox dysregulation as underlying mechanisms...
2024: Frontiers in Psychiatry
https://read.qxmd.com/read/38412242/fluorophore-label-free-light-up-near-infrared-deoxyribonucleic-acid-nanosensor-for-monitoring-extracellular-potassium-levels
#17
JOURNAL ARTICLE
Zhiwei Deng, Jiacheng Ding, Jiaqi Bu, Jiacheng Li, Hui Liu, Peiru Gao, Zan Gong, Xiangxiang Qin, Yanjing Yang, Shian Zhong
Fluorescent DNA nanosensors have been widely used due to their unique advantages, among which the near-infrared (NIR) imaging mode can provide deeper penetration depth and lower biological background for the nanosensors. However, efficient NIR quenchers require ingenious design, complex synthesis, and modification, which severely limit the development of NIR DNA nanosensors. Label-free strategies based on G-quadruplex (G4) and NIR G4 dyes were first introduced into in situ extracellular imaging, and a novel NIR sensing strategy for the specific detection of extracellular targets is proposed...
February 27, 2024: Analytical Chemistry
https://read.qxmd.com/read/38385826/low-grade-parental-gonosomal-mosaicism-in-chd2-siblings-with-smith-magenis-like-syndrome
#18
JOURNAL ARTICLE
Francesca Cogliati, Letizia Straniero, Valeria Rimoldi, Maura Masciadri, Sara Perego, Berardo Rinaldi, Donatella Milani, Davide Gentilini, Lidia Larizza, Rosanna Asselta, Silvia Russo, Maria Francesca Bedeschi
Loss-of-function CHD2 (chromodomain helicase DNA-binding protein 2) mutations are associated with a spectrum of neurodevelopmental disorders often including early-onset generalized seizures, photosensitivity, and epileptic encephalopathies. Patients show psychomotor delay/intellectual disability (ID), autistic features, and behavior disorders, such as aggression and impulsivity. Most reported cases are sporadic with description of germline mosaicism only in two families. We detect the first case of parental gonosomal CHD2 mosaicism disclosed by two brothers showing mild ID, born to healthy parents...
February 22, 2024: American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics
https://read.qxmd.com/read/38385069/the-nad-precursor-nicotinamide-riboside-rescues-mitochondrial-defects-and-neuronal-loss-in-ipsc-derived-cortical-organoid-of-alpers-disease
#19
JOURNAL ARTICLE
Yu Hong, Zhuoyuan Zhang, Tsering Yangzom, Anbin Chen, Bjørn Christian Lundberg, Evandro Fei Fang, Richard Siller, Gareth John Sullivan, Jiri Zeman, Charalampos Tzoulis, Laurence A Bindoff, Kristina Xiao Liang
Alpers' syndrome is an early-onset neurodegenerative disorder usually caused by biallelic pathogenic variants in the gene encoding the catalytic subunit of polymerase-gamma (POLG), which is essential for mitochondrial DNA (mtDNA) replication. The disease is progressive, incurable, and inevitably it leads to death from drug-resistant status epilepticus. The neurological features of Alpers' syndrome are intractable epilepsy and developmental regression, with no effective treatment; the underlying mechanisms are still elusive, partially due to lack of good experimental models...
2024: International Journal of Biological Sciences
https://read.qxmd.com/read/38351292/identification-of-the-dna-methylation-signature-of-mowat-wilson-syndrome
#20
JOURNAL ARTICLE
Stefano Giuseppe Caraffi, Liselot van der Laan, Kathleen Rooney, Slavica Trajkova, Roberta Zuntini, Raissa Relator, Sadegheh Haghshenas, Michael A Levy, Chiara Baldo, Giorgia Mandrile, Carolyn Lauzon, Duccio Maria Cordelli, Ivan Ivanovski, Anna Fetta, Elena Sukarova, Alfredo Brusco, Lisa Pavinato, Verdiana Pullano, Marcella Zollino, Haley McConkey, Marco Tartaglia, Giovanni Battista Ferrero, Bekim Sadikovic, Livia Garavelli
Mowat-Wilson syndrome (MOWS) is a rare congenital disease caused by haploinsufficiency of ZEB2, encoding a transcription factor required for neurodevelopment. MOWS is characterized by intellectual disability, epilepsy, typical facial phenotype and other anomalies, such as short stature, Hirschsprung disease, brain and heart defects. Despite some recognizable features, MOWS rarity and phenotypic variability may complicate its diagnosis, particularly in the neonatal period. In order to define a novel diagnostic biomarker for MOWS, we determined the genome-wide DNA methylation profile of DNA samples from 29 individuals with confirmed clinical and molecular diagnosis...
February 13, 2024: European Journal of Human Genetics: EJHG
keyword
keyword
31504
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.